Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements
Year: 2003
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: Journal of Hypertension
Institution: Boehringer Ingelheim (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1965573335
